Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 791 shares (to pay taxes)
  2. 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 801 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,585 shares (to pay taxes)
  10. 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 1,710 shares (to pay taxes)
  11. 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 856 shares (to pay taxes)
  12. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 5,452 shares (to pay taxes)
  13. 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,453 shares (to pay taxes)
  14. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 890 shares (to pay taxes)
  15. 4 Open-market sale Director sold 21,959 shares at $16.15 ($354,638)
  16. 4 Open-market sale CHIEF MEDICAL OFFICER sold 28,357 shares at $15.18 ($430,459)
  17. 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 52 shares (to pay taxes)
  18. 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 563 shares (to pay taxes)
  19. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 1,929 shares (to pay taxes)
  20. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 507 shares (to pay taxes)

Page 12 of 20 · 386 filings